• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRALEX ST; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRALEX ST; SURGICAL MESH Back to Search Results
Catalog Number 5950007
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Scar Tissue (2060)
Event Date 11/02/2016
Event Type  Injury  
Manufacturer Narrative
As reported, about one month post-implant of bard/davol ventralex st mesh, the patient was diagnosed with small area of fibrinous healing tissue and was treated with medication.As reported, the ae has resolved.The clinician has assessed the patient¿s postoperative course as being ¿possibly¿ related to the study device and definitely related to the index procedure, however, based on the information provided, no conclusion can be made.Not returned - remains implanted.
 
Event Description
Reported per clinical trial (b)(6): on (b)(6) 2016 - subject patient underwent a primary open laparotomy midline umbilical hernia (1.5cm x 2.5 cm) repair procedure during which a bard/davol ventralex st was placed in underlay fashion in an intra-peritoneally and was fixated using suture.The fascia and full skin closure was achieved using sutures and adhesive skin closure.The patient was discharged on (b)(6) 2016.On (b)(6) 2016 - fibrinous healing tissue and was prescribed with application of sulfasalazine topically for 1-2 weeks until fully healed.On (b)(6) 2017 - the ae is resolved.Per the study clinician, the reported adverse event has been assessed as moderate in severity, possibly related to the study device and definitely related to the index procedure.The outcome for this ae is reported as recovered/resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENTRALEX ST
Type of Device
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key14488541
MDR Text Key292507526
Report Number1213643-2022-00306
Device Sequence Number1
Product Code FTL
UDI-Device Identifier00801741031472
UDI-Public(01)00801741031472
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K101928
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Study,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/28/2017
Device Catalogue Number5950007
Device Lot NumberHUZI0813
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient SexFemale
Patient Weight84 KG
-
-